Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2532 - A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Surviva
Presenter(s)
Yupei Yuan, MD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing